Hosted on MSN28d
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro ...
Business Facilities29d
Lilly Will Invest Additional $5.3B In Indiana Pharmaceutical Manufacturing
New investment brings Lilly’s total commitment at LEAP Research and Innovation District in Lebanon to $9 billion, 900 new jobs. In addition to the new investment, Lilly will create another ...
Bisnow29d
Eli Lilly To Invest Record $5.3B To Expand Plant That Manufactures Weight-Loss Drugs
Eli Lilly plans to invest an additional $5.3B to manufacture more of its blockbuster weight-loss and diabetes treatments at its Indiana plant, the pharma giant announced Friday. The expansion is ...
FiercePharma29d
Eli Lilly invests additional $5.3B for production of diabetes, obesity drugs in Indiana
Since scoring approval two years ago for its next-generation diabetes treatment Mounjaro (tirzepatide), Eli Lilly has been playing catch up with market leader Novo Nordisk. On Friday, the ...
Ibj.com29d
Lilly’s huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound
Eli Lilly and Co.’s decision to invest another $5.3 billion in its Boone County manufacturing complex was one of the fastest the company has made in recent history, in an effort to turbo-charge ...
The Indianapolis Star28d
Eli Lilly and Co., increases LEAP District investment to $9B for weight loss drug
Eli Lilly and Co., is more than doubling its investment in its Boone County manufacturing site to increase production of ingredients in its blockbuster weight loss and diabetes drugs. The ...
Ibj.com29d
Lilly to invest another $5.3B in Lebanon site to meet overwhelming demand for Mounjaro, Zepbound
Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment Zepbound, Indianapolis-based drugmaker Eli Lilly and Co. said Friday morning it plans to invest another ...
Forbes28d
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Eli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting production for its weight loss and diabetes medications Mounjaro and Zepbound, the pharmaceutical firm said ...
NBC New York5d
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Eli Lilly has more work it wants to do with the hard-won success from its weight loss and diabetes drugs, Zepbound and Mounjaro, outgoing CFO Anat Ashkenazi told CNBC. The company is working to ...
Benzinga.com28d
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
The expansion will enhance Lilly's capacity to manufacture tirzepatide, an active pharmaceutical ingredient for Zepbound and Mounjaro. Eli Lilly expects to begin making medicines in Lebanon ...
Independent Tribune7d
'It's a great day for North Carolina.' Eli Lilly unveils sign, debuts new manufacturing facility
Governor Roy Coope, Eli Lilly officials and others were on hand as the new $2 billion facility opened on Concord Friday, June ...